SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10205O'Shea trading plan: sell as fast as possible.rkrw-10/31/2007
10204O'Shea (a vice Chairman these days) held 9.254 shares in a blind trust - whaIcebrg-10/31/2007
10203BofA... Sepracor (SEPR, 26.37, Buy, tp40, cap3b): 3Q07 EPS of $0.37, versus ourkrw-10/31/2007
10202My sense is that SEPR has been forced to a "hold" strategy instead of kenhott-10/31/2007
10201Don't you know that people can work at a 110%?kenhott-10/31/2007
10200Amen to that. [He should concentrate 100 per cent on his own company. That is rkrw-10/30/2007
10199Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors Tuesday OctoberIcebrg-10/30/2007
10198Almost all of the guide up for 2008 EPS is the reduction in force/cost saves assRobohogs-10/30/2007
10197Sepracor Inc. Announces Third Quarter 2007 Results and Planned Reduction in Operkenhott-10/30/2007
10196Sepracor lawsuit might block drug Rivals planning generic version By Susan DecIcebrg-10/24/2007
10195Lunesta Moth Flies to Drug-Ad Championship Posted by Jacob Goldstein October 2Doc Bones-10/23/2007
10194Tim Barberich, a silky smooth escape act worthy of Houdini, but a lot more lucraquidditch-10/22/2007
10193Sepracor Falls on Analyst Downgrade Monday October 22, 5:27 pm ET Sepracor Dropstnsaf-10/22/2007
10192Jon/Rocky, Have not seen the scripts so far. Anything update? Thanks a millioal1998-10/11/2007
10191Fairly superficial analysis by S&P of the insomnia market: businessweek.comtuck-10/11/2007
10190. . . However, with total annual sales in Europe stagnating over 2005 and 2006 Icebrg-10/9/2007
10189Here's another value for your equation . . . InVivoBlog estimatestuck-10/9/2007
10188Is that new math? :) I think Mr. Market has given it a good valuation and writkenhott-10/2/2007
10187What do you think of this equation: Low share price + weak dollar + marketing aBMcV-10/2/2007
10186<get the paddles> lol. Thanks and to Rocky too. Looking to spot up a pokenhott-10/2/2007
10185Sept 21: L 129,250 flat line, get the paddles MDI 68,406 with share of overallRobohogs-10/2/2007
10184New prescription allergy treatment XYZAL(R) (levocetirizine dihydrochloride) nowIcebrg-10/2/2007
10183Trial Date Set for Patent Infringement Suit Against Sepracor's Brovana(TM) Icebrg-9/25/2007
10182For Sept 14: L 130,898 MDI 66,582 B 984 For Sept 7: L 124,172 60,162 B 898 IRobohogs-9/25/2007
10181Tax cut may go to drug maker Sepracor plans large expansion By Bob Kievra TELEGRIcebrg-9/22/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News